Brand-name drug
Vivelle price, strengths & recalls
Brand of estradiol (generic)
Pharmacies pay $515.72 for 28 ds of Vivelle 0.00313 mg/hr (84 hr) patch this week, and from $514.54 to $515.72 across its 5 priced strengths and forms. The generic, estradiol, costs pharmacies from $1.86. It has 253 recalls on record, none ongoing. Its official label last changed on November 5, 2026.
Brand- Fair cash price
- $603.58
- Strengths
- 5
- Makers
- 1
- Updated
- Nov 11
Vivelle price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 0.00104 mg/hr (84 hr) patch Brand | $18.38 | $514.54 / 28 ds |
| 0.00156 mg/hr (84 hr) patch Brand | $18.38 | $514.67 / 28 ds |
| 0.00208 mg/hr (84 hr) patch Brand | $18.40 | $515.11 / 28 ds |
| 0.00313 mg/hr (84 hr) patch Brand | $18.42 | $515.72 / 28 ds |
| 0.00417 mg/hr (84 hr) patch Brand | $18.40 | $515.26 / 28 ds |
Vivelle vs generic estradiol
Generics have the same active ingredient, strength and form, and FDA requires them to work the same way. What pharmacies pay for each, same quantity:
| Strength | Brand | Generic | Brand costs |
|---|---|---|---|
| 0.00104 mg/hr (84 hr) patch | $514.54 | $224.30 | 2.3x |
| 0.00156 mg/hr (84 hr) patch | $514.67 | $231.17 | 2.2x |
| 0.00208 mg/hr (84 hr) patch | $515.11 | $241.11 | 2.1x |
| 0.00313 mg/hr (84 hr) patch | $515.72 | $230.56 | 2.2x |
| 0.00417 mg/hr (84 hr) patch | $515.26 | $244.51 | 2.1x |
Supply status: shortages & recalls
Recalls
Showing the 6 most relevant of 253 - all recalls.
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Vivelle
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use VIVELLE-DOT safely and effectively. See full prescribing information for VIVELLE-DOT.VIVELLE-DOT® (estradiol transdermal system)Initial U.S. Approval: 1996
WARNING: ENDOMETRIAL CANCER WITH UNOPPOSED ESTROGEN IN WOMEN WITH A UTERUS
•
There is an increased risk of endometrial cancer in a woman with a uterus who uses unopposed estrogens. Adding a progestogen to estrogen-only therapy has been shown to reduce the risk of endometrial hyperplasia, which may be a precursor to endometrial cancer.
•
Perform adequate diagnostic measures, including directed or random endometrial sampling when indicated, to rule out malignancy in menopausal women with abnormal genital bleeding of unknown etiology [see Warnings and Precautions (5.2)].
WARNING: ENDOMETRIAL CANCER WITH UNOPPOSED ESTROGEN IN WOMEN WITH A UTERUS
See full prescribing information for complete boxed warning.
There is an increased risk of endometrial cancer in a woman with a uterus who uses unopposed estrogens (5.2)
Recent major changes (as listed on the label)
Boxed Warning, Cardiovascular Disorders, Breast Cancer, Probable Dementia 10/2026
Dosage and Administration, Important Use Information (2.1) 10/2026
Contraindications (4) 10/2026
Warnings and Precautions, Cardiovascular Disorders (5.1) 10/2026
Warnings and Precautions, Malignant Neoplasms (5.2) 10/2026
Warnings and Precautions, Risks Associated with Concomitant of Estrogen Plus Progestogen (5.3) 10/2026
Warnings and Precautions, Probable Dementia removed 10/2026
Warnings and Precautions, Addition of a Progestogen When a Woman Has Not Had a Hysterectomy removed 10/2026
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA020538 · Sandoz
- First approved
- July 31, 1996 (30 years ago)
- Latest approved change
- October 30, 2026
- Approved label
- PDF, Oct 30, 2026
- Generic makers
- 31 approved generic applications on the market
Vivelle questions
How much does vivelle cost without insurance?
Pharmacies pay about $515.72 for 28 ds of vivelle 0.00313 mg/hr (84 hr) patch ($18.42 per unit). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $603.58. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is there a generic for Vivelle?
Yes: estradiol. Pharmacies pay from $1.86 for it. Compare estradiol prices.
Is vivelle in shortage?
No shortage is reported for vivelle right now. We check the national shortage list every day.
Has vivelle been recalled?
253 recalls on record, none ongoing. Recalls name specific lots - check yours.
When did the vivelle label last change?
The official label was last updated on November 5, 2026 (version 19). See what changed.
Talk about vivelle
No comments yet. Questions, tips, what worked for you - start the conversation.